Trial Search Results

Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms

The primary objective of this study is to evaluate the long-term safety and tolerability of orally administered telotristat etiprate.

Stanford is currently not accepting patients for this trial.

Stanford Investigator(s):

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
CCTO
650-498-7061
Not Recruiting